News
All the latest fundraises and exits from Asian-heritage founders in the UK.
Holly Health Secures £650K Funding for Innovative Healthcare Solutions
£650K
Revolutionising Biotech: Mytos Secures $19M Series A Funding for Automated Cell Manufacturing"
$19M
Plumm Funding: £2.2M in B2B Mental Health Support Platform
£2.2M
Automata Technologies Secures $40 Million Funding to Accelerate Lab Automation Innovation
$40M
Pencil Biosciences Secures £5.6 Million Funding for Innovative Gene Editing Technology
£5.6M
Kuano Raises £1.8M in Seed Funding Round for Quantum Drug Discovery
£1.8M
Fertifa Secures £5 Million Funding to Expand Reproductive Health Benefits Platform
£5M
GetHarley Raises $52M To Transform Skincare Platform
$52M
OMass Therapeutics Secures £10 Million Funding Boost: Accelerating Drug Development
£10M
Revolutionising Cancer Treatment: Pear Bio Secures $14M Series A Funding
$14M
MediShout Secures £4.3 Million Funding to Revolutionise Hospital Operations
£4.3M
MultiOmic Health Secures $6.2 Million Funding Boost
$6.2M
TympaHealth Secures $23M Funding to Revolutionse Ear and Hearing Healthcare
$23M
DrDoctor Secures £10 Million Funding to Revolutionise Healthcare Delivery
£10M
EnvisionIt Deep AI Secures $1.65M Investment for Healthcare Innovation
$1.65M
Empowering Healthcare Decisions: Doctify Raises $10M to Expand Global Reach
$10M
Phlo Secures £10M Series A Funding to Propel Digital Pharmacy Expansion
£10M
WeLinq Secures €5 Million Funding to Propel Quantum Computing Innovations
€5M
Oxford Cancer Analytics (OXcan): Pioneering Early Cancer Detection with £3M Funding Boost
£3M
Peppy: Pioneering Personalised Gender-Based Healthcare Goes Global with $45M Series B Funding
$45M
Perspectum Secures $36 Million in Series C Funding Led by Oppenheimer Holdings
$36M
Charm Therapeutics Secures $50 Million Funding Boost for Cancer Treatment Innovations
$50M
Concr Secures £1.22 Million in Seed Funding for Oncology Biomarker Discovery
£1.22M
Walking on Earth Secures £3M Seed Funding to Revolutionise Workplace Stress Management
£3M
DefiniGEN Secures £3.25 Million in Funding to Propel Research and Development
£3.25M